ベンチャー探訪　Alnylam社の創業者が参画するCity社、日本発技術取り入れ次世代のsiRNA創薬 | AN Venture Partners

ベンチャー探訪　Alnylam社の創業者が参画するCity社、日本発技術取り入れ次世代のsiRNA創薬

MediaPortfolio Companies

ベンチャー探訪　Alnylam社の創業者が参画するCity社、日本発技術取り入れ次世代のsiRNA創薬

January 17, 2025

City Therapeutics successfully completes its Nasdaq IPO

Press Release

Portfolio Companies

City Therapeutics successfully completes its Nasdaq IPO

San Francisco, October 19, 2026

Typewriter Therapeutics Emerges from Stealth with $56 Million Series A Financing to pursue in vivo CAR T medicines

Press Release

Portfolio Companies

Typewriter Therapeutics Emerges from Stealth with $56 Million Series A Financing to pursue in vivo CAR T medicines

Cambridge, Mass., September 2, 2026

Privacy Policy

This website uses Google Analytics cookies for access analysis only. The collected data is used solely for improving the website and is handled appropriately. By clicking "AGREE", you consent to the use of cookies.

Privacy Policy

This website uses Google Analytics cookies for access analysis only. The collected data is used solely for improving the website and is handled appropriately. By clicking "AGREE", you consent to the use of cookies.